Surge in Options Trading Volume for Enovix and Clover Health
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 06 2026
0mins
Source: NASDAQ.COM
- Enovix Options Volume: Enovix Corp saw options trading volume of 47,349 contracts, equivalent to approximately 4.7 million shares, representing about 85% of its average daily trading volume of 5.6 million shares over the past month, indicating heightened market interest in its future performance.
- High-Frequency Trading: Notably, the $7 strike call option expiring on October 16, 2026, has seen 11,736 contracts traded today, representing around 1.2 million underlying shares, suggesting increased investor expectations for Enovix's stock price appreciation.
- Clover Options Activity: Clover Health Investments Corp recorded options trading volume of 45,122 contracts, approximately 4.5 million shares, which accounts for about 80% of its average daily trading volume of 5.6 million shares over the past month, reflecting active market interest in its stock.
- Clover High-Frequency Trading: The $2 strike call option expiring on April 10, 2026, has seen 13,076 contracts traded today, representing about 1.3 million underlying shares, indicating optimistic sentiment among investors regarding Clover's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AEHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AEHR
Wall Street analysts forecast AEHR stock price to fall
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 109.920
Low
21.00
Averages
25.00
High
29.00
Current: 109.920
Low
21.00
Averages
25.00
High
29.00
About AEHR
Aehr Test Systems, Inc. offers test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer level, singulated die, and package part form. Its products include the FOX-P family of test and burn-in systems and FOX WaferPak Aligner, FOX WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in and stabilize a range of devices such as silicon carbide-based and other power semiconductors, 2D and 3D sensors used in phones, tablets and other computing devices. FOX-CP system is a single-wafer compact test solution for logic, memory and photonic devices. FOX WaferPak Contactor contains a full wafer contactor capable of testing wafers up to 300 millimeters that enables integrated circuit manufacturers to perform testing, burn-in and stabilization of full wafers on the FOX-P systems. It offers packaged part reliability/burn-in test solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aehr Test Systems Stock Soars 16.2% Following Vicor's Revenue Guidance Raise
- Stock Surge: Aehr Test Systems' stock surged 16.2% to $14.94 per share this afternoon, reflecting market optimism about its growth prospects, particularly against the backdrop of strong demand in the AI infrastructure sector.
- Vicor Guidance Raise: Vicor unexpectedly raised its second-quarter revenue guidance, driven by rising product revenues and royalties from an additional licensee of its patented power system technology, indicating accelerating demand for data center power solutions that indirectly benefits Aehr's market outlook.
- Order Explosion: Aehr recently secured a $41 million order from its lead hyperscaler customer, pushing its total orders for the second half of fiscal 2026 to over $92 million, significantly exceeding its previous guidance of $60 million to $80 million, highlighting strong demand for its testing equipment.
- Profitability Outlook: Although Aehr is a couple of years away from profitability, the ongoing growth in orders will bolster investor confidence, and if Vicor's positive signals continue, Aehr may receive more orders in the future, further solidifying its position in the AI data center market.
See More
Vicor's Guidance Boosts Aehr Test Systems Amid Strong AI Demand
- Strong Demand Signal: Vicor's unexpected second-quarter revenue guidance increase indicates rising demand for AI infrastructure, positively impacting Aehr Test Systems, which saw its stock price soar by 16.2%.
- Orders Exceed Expectations: Aehr Test Systems reported over $92 million in orders for the second half of fiscal 2026, significantly surpassing its previous guidance of $60 million to $80 million, highlighting its robust growth potential in the AI infrastructure sector.
- Expanding Customer Base: Aehr recently secured a $41 million order from a leading hyperscaler, further solidifying its position in the power semiconductor and AI processor testing equipment market, suggesting potential for continued order growth.
- Profitability Challenges: Despite significant order growth, Aehr faces challenges in achieving profitability, which is crucial for bolstering investor confidence and ensuring sustainable development in a competitive market.
See More
Underrated AI Stocks to Watch This Month
- Aehr Test Systems Performance: Aehr Test Systems (AEHR) has seen its stock price soar 379% year-to-date and an astonishing 961% over the past year, reflecting strong demand for its AI chip testing equipment, particularly in data centers and electric vehicles, which is likely to continue attracting investor interest.
- Backlog Fuels Growth: The company reported in its Q3 FY2026 earnings that it only generated $10 million in revenue in Q1 but booked $37 million in future business, and later secured a $41 million contract from a major client, boosting total bookings to approximately $92 million, indicating robust market demand.
- ServiceNow's Challenges and Opportunities: ServiceNow (NOW) has faced a 42% decline in stock price this year, yet it achieved a 22% year-over-year revenue growth and beat earnings expectations in Q1, despite short-term pressures from delayed contracts in the Middle East, with an expected subscription guidance increase to 22% to 22.5% for 2026, showcasing its long-term growth potential.
- Market Outlook and Analyst Ratings: Despite short-term profitability challenges, ServiceNow's remaining performance obligations stand at $27.7 billion, representing a 25% year-over-year growth, and with 90% of analysts rating it a buy and a median price target of $137.50, suggesting a 57% upside, indicating strong market confidence in its future performance.
See More
Aehr Test Systems Stock Soars 327% Amid AI Boom
- Outstanding Market Performance: Aehr Test Systems has seen its stock price soar by 327% in 2026, significantly outperforming competitors like Nvidia, Broadcom, and AMD, indicating strong demand and leadership in the semiconductor testing equipment market.
- Significant Order Growth: The company reported a total of $92 million in bookings, including a record $41 million production order from a hyperscaler customer, highlighting its expanding market share in data center testing.
- Optimistic Financial Outlook: Although revenue for the most recent quarter was around $10 million, Aehr anticipates fiscal year 2026 revenue between $45 million and $50 million, reflecting strong order backlogs and future growth potential.
- Analysts Favor Long-Term Prospects: Despite the current stock being viewed as overvalued, analysts remain optimistic about Aehr's long-term outlook, projecting a 71% revenue growth in fiscal 2027 and an increase in earnings from a net loss of $0.09 per share to $0.15 per share.
See More
Aehr Test Systems Stock Soars 327% Amid AI Boom
- Stock Performance: Aehr Test Systems has seen its stock price surge 327% year-to-date in 2026, reflecting strong demand for its semiconductor testing equipment amid the AI boom.
- Market Leadership: Aehr is recognized as a leader in wafer-level testing, and despite facing competition from international players, it continues to grow its market share in EV and data center testing, with an increasing revenue contribution from data centers.
- Order Growth: The company reported expected annual revenue between $45 million and $50 million, along with $37 million in bookings, indicating robust market demand and significant growth potential ahead.
- Analyst Outlook: While the current stock price is viewed as overvalued, analysts remain optimistic about Aehr's long-term prospects, forecasting a 71% revenue growth in fiscal 2027 and an increase in earnings per share from a net loss of $0.09 to $0.15 this fiscal year.
See More
Aehr Test Systems Shares Surge 144.2% Amid Explosive Order Growth
- Stock Surge: Aehr Test Systems' shares skyrocketed by 144.2% in April 2026, indicating a doubling of stock price within a month, reflecting strong market confidence in the company's future growth prospects.
- Backlog Growth: By the end of Q3 2026, Aehr's backlog of unfilled orders reached $38.7 million, significantly up from $18.2 million a year ago, providing robust support for future revenues and indicating strong market demand.
- Historic Order: On April 16, Aehr secured its largest order ever, a $41 million follow-on order from an existing hyperscale customer, with revenue-generating shipments expected to commence in fiscal year 2027, further driving revenue growth.
- Market Trend Impact: Despite reporting net losses and sales below expectations in Q3 2026, investors remain optimistic about Aehr's strong order growth in the semiconductor sector, reflecting confidence in the company's future development.
See More
Aehr Test Systems Stock Soars 16.2% Following Vicor's Revenue Guidance Raise
- Stock Surge: Aehr Test Systems' stock surged 16.2% to $14.94 per share this afternoon, reflecting market optimism about its growth prospects, particularly against the backdrop of strong demand in the AI infrastructure sector.
- Vicor Guidance Raise: Vicor unexpectedly raised its second-quarter revenue guidance, driven by rising product revenues and royalties from an additional licensee of its patented power system technology, indicating accelerating demand for data center power solutions that indirectly benefits Aehr's market outlook.
- Order Explosion: Aehr recently secured a $41 million order from its lead hyperscaler customer, pushing its total orders for the second half of fiscal 2026 to over $92 million, significantly exceeding its previous guidance of $60 million to $80 million, highlighting strong demand for its testing equipment.
- Profitability Outlook: Although Aehr is a couple of years away from profitability, the ongoing growth in orders will bolster investor confidence, and if Vicor's positive signals continue, Aehr may receive more orders in the future, further solidifying its position in the AI data center market.
See More
Vicor's Guidance Boosts Aehr Test Systems Amid Strong AI Demand
- Strong Demand Signal: Vicor's unexpected second-quarter revenue guidance increase indicates rising demand for AI infrastructure, positively impacting Aehr Test Systems, which saw its stock price soar by 16.2%.
- Orders Exceed Expectations: Aehr Test Systems reported over $92 million in orders for the second half of fiscal 2026, significantly surpassing its previous guidance of $60 million to $80 million, highlighting its robust growth potential in the AI infrastructure sector.
- Expanding Customer Base: Aehr recently secured a $41 million order from a leading hyperscaler, further solidifying its position in the power semiconductor and AI processor testing equipment market, suggesting potential for continued order growth.
- Profitability Challenges: Despite significant order growth, Aehr faces challenges in achieving profitability, which is crucial for bolstering investor confidence and ensuring sustainable development in a competitive market.
See More
Underrated AI Stocks to Watch This Month
- Aehr Test Systems Performance: Aehr Test Systems (AEHR) has seen its stock price soar 379% year-to-date and an astonishing 961% over the past year, reflecting strong demand for its AI chip testing equipment, particularly in data centers and electric vehicles, which is likely to continue attracting investor interest.
- Backlog Fuels Growth: The company reported in its Q3 FY2026 earnings that it only generated $10 million in revenue in Q1 but booked $37 million in future business, and later secured a $41 million contract from a major client, boosting total bookings to approximately $92 million, indicating robust market demand.
- ServiceNow's Challenges and Opportunities: ServiceNow (NOW) has faced a 42% decline in stock price this year, yet it achieved a 22% year-over-year revenue growth and beat earnings expectations in Q1, despite short-term pressures from delayed contracts in the Middle East, with an expected subscription guidance increase to 22% to 22.5% for 2026, showcasing its long-term growth potential.
- Market Outlook and Analyst Ratings: Despite short-term profitability challenges, ServiceNow's remaining performance obligations stand at $27.7 billion, representing a 25% year-over-year growth, and with 90% of analysts rating it a buy and a median price target of $137.50, suggesting a 57% upside, indicating strong market confidence in its future performance.
See More
Aehr Test Systems Stock Soars 327% Amid AI Boom
- Outstanding Market Performance: Aehr Test Systems has seen its stock price soar by 327% in 2026, significantly outperforming competitors like Nvidia, Broadcom, and AMD, indicating strong demand and leadership in the semiconductor testing equipment market.
- Significant Order Growth: The company reported a total of $92 million in bookings, including a record $41 million production order from a hyperscaler customer, highlighting its expanding market share in data center testing.
- Optimistic Financial Outlook: Although revenue for the most recent quarter was around $10 million, Aehr anticipates fiscal year 2026 revenue between $45 million and $50 million, reflecting strong order backlogs and future growth potential.
- Analysts Favor Long-Term Prospects: Despite the current stock being viewed as overvalued, analysts remain optimistic about Aehr's long-term outlook, projecting a 71% revenue growth in fiscal 2027 and an increase in earnings from a net loss of $0.09 per share to $0.15 per share.
See More
Aehr Test Systems Stock Soars 327% Amid AI Boom
- Stock Performance: Aehr Test Systems has seen its stock price surge 327% year-to-date in 2026, reflecting strong demand for its semiconductor testing equipment amid the AI boom.
- Market Leadership: Aehr is recognized as a leader in wafer-level testing, and despite facing competition from international players, it continues to grow its market share in EV and data center testing, with an increasing revenue contribution from data centers.
- Order Growth: The company reported expected annual revenue between $45 million and $50 million, along with $37 million in bookings, indicating robust market demand and significant growth potential ahead.
- Analyst Outlook: While the current stock price is viewed as overvalued, analysts remain optimistic about Aehr's long-term prospects, forecasting a 71% revenue growth in fiscal 2027 and an increase in earnings per share from a net loss of $0.09 to $0.15 this fiscal year.
See More
Aehr Test Systems Shares Surge 144.2% Amid Explosive Order Growth
- Stock Surge: Aehr Test Systems' shares skyrocketed by 144.2% in April 2026, indicating a doubling of stock price within a month, reflecting strong market confidence in the company's future growth prospects.
- Backlog Growth: By the end of Q3 2026, Aehr's backlog of unfilled orders reached $38.7 million, significantly up from $18.2 million a year ago, providing robust support for future revenues and indicating strong market demand.
- Historic Order: On April 16, Aehr secured its largest order ever, a $41 million follow-on order from an existing hyperscale customer, with revenue-generating shipments expected to commence in fiscal year 2027, further driving revenue growth.
- Market Trend Impact: Despite reporting net losses and sales below expectations in Q3 2026, investors remain optimistic about Aehr's strong order growth in the semiconductor sector, reflecting confidence in the company's future development.
See More
